In our cohort, the atypical chemokine-like factor MIF was present at higher concentrations in NAFLD sera, particularly in sera from patients with cirrhosis, whereas its concentration was lowest in sera of patients with HCC in cirrhosis. This evidence concerns the gene MIF and metabolic dysfunction-associated steatotic liver disease.